These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 36219214

  • 21. Clinical and pathological characteristics of ocular surface squamous neoplasia in an Asian population.
    Kim BH, Kim MK, Wee WR, Oh JY.
    Graefes Arch Clin Exp Ophthalmol; 2013 Nov; 251(11):2569-73. PubMed ID: 24006080
    [Abstract] [Full Text] [Related]

  • 22. Boston type 1 keratoprosthesis: the university of california davis experience.
    Bradley JC, Hernandez EG, Schwab IR, Mannis MJ.
    Cornea; 2009 Apr; 28(3):321-7. PubMed ID: 19387235
    [Abstract] [Full Text] [Related]

  • 23. The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency.
    Sejpal K, Yu F, Aldave AJ.
    Cornea; 2011 Nov; 30(11):1187-94. PubMed ID: 21885964
    [Abstract] [Full Text] [Related]

  • 24. [Allogeneic cultured limbal epithelial transplantation: a clinical observation of its treatment effects on large conjunctival lesions].
    Cheng J, Wang JY, Duan HY, Wang S, Cong L, Xie LX.
    Zhonghua Yan Ke Za Zhi; 2017 Mar 11; 53(3):172-176. PubMed ID: 28316190
    [Abstract] [Full Text] [Related]

  • 25. Combined phototherapeutic keratectomy and amniotic membrane grafts for symptomatic bullous keratopathy.
    Vyas S, Rathi V.
    Cornea; 2009 Oct 11; 28(9):1028-31. PubMed ID: 19724207
    [Abstract] [Full Text] [Related]

  • 26. The Boston keratoprosthesis type II: the Massachusetts Eye and Ear Infirmary experience.
    Pujari S, Siddique SS, Dohlman CH, Chodosh J.
    Cornea; 2011 Dec 11; 30(12):1298-303. PubMed ID: 21963861
    [Abstract] [Full Text] [Related]

  • 27. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b.
    Boehm MD, Huang AJ.
    Ophthalmology; 2004 Sep 11; 111(9):1755-61. PubMed ID: 15350333
    [Abstract] [Full Text] [Related]

  • 28. Therapeutic use of the 193-nm excimer laser in corneal pathologies.
    Förster W, Atzler U, Ratkay I, Busse H.
    Graefes Arch Clin Exp Ophthalmol; 1997 May 11; 235(5):296-305. PubMed ID: 9176678
    [Abstract] [Full Text] [Related]

  • 29. Long-term Visual Outcomes and Complications of Boston Keratoprosthesis Type II Implantation.
    Lee R, Khoueir Z, Tsikata E, Chodosh J, Dohlman CH, Chen TC.
    Ophthalmology; 2017 Jan 11; 124(1):27-35. PubMed ID: 27538795
    [Abstract] [Full Text] [Related]

  • 30. Cultured corneal epithelia for ocular surface disease.
    Schwab IR.
    Trans Am Ophthalmol Soc; 1999 Jan 11; 97():891-986. PubMed ID: 10703147
    [Abstract] [Full Text] [Related]

  • 31. [Amniotic membrane graft in ocular surface disease. Prospective study with 31 cases].
    Muraine M, Descargues G, Franck O, Villeroy F, Toubeau D, Menguy E, Martin J, Brasseur G.
    J Fr Ophtalmol; 2001 Oct 11; 24(8):798-812. PubMed ID: 11894530
    [Abstract] [Full Text] [Related]

  • 32. Long-Term Outcome After Superficial Keratectomy of the Abnormal Epithelium for Partial Limbal Stem Cell Deficiency.
    Matsumura T, Yamaguchi T, Higa K, Inatani M, Shimazaki J.
    Am J Ophthalmol; 2021 Nov 11; 231():134-143. PubMed ID: 34102156
    [Abstract] [Full Text] [Related]

  • 33. Surgical amniotic membrane transplantation after conjunctival and limbal tumor excision.
    Goktas SE, Katircioglu Y, Celik T, Ornek F.
    Arq Bras Oftalmol; 2017 Nov 11; 80(4):242-246. PubMed ID: 28954025
    [Abstract] [Full Text] [Related]

  • 34. Boston type 1 keratoprosthesis: the New York Eye and Ear experience.
    Patel AP, Wu EI, Ritterband DC, Seedor JA.
    Eye (Lond); 2012 Mar 11; 26(3):418-25. PubMed ID: 22173079
    [Abstract] [Full Text] [Related]

  • 35. Amniotic membrane transplantation in acute phase of toxic epidermal necrolysis with severe corneal involvement.
    Kobayashi A, Yoshita T, Sugiyama K, Miyashita K, Niida Y, Koizumi S, Tseng SC.
    Ophthalmology; 2006 Jan 11; 113(1):126-32. PubMed ID: 16324747
    [Abstract] [Full Text] [Related]

  • 36. Long-term outcomes of the MICOF keratoprosthesis surgery.
    Wang L, He X, Wang Q, Wu T, Liu A, Huang Y.
    Ocul Surf; 2021 Jul 11; 21():178-185. PubMed ID: 34118425
    [Abstract] [Full Text] [Related]

  • 37. Management of intraepithelial and invasive neoplasia of the cornea and conjunctiva: a long-term follow up.
    Zaki AA, Farid SF.
    Cornea; 2009 Oct 11; 28(9):986-8. PubMed ID: 19724215
    [Abstract] [Full Text] [Related]

  • 38. Phototherapeutic keratectomy versus diamond burr polishing of Bowman's membrane in the treatment of recurrent corneal erosions associated with anterior basement membrane dystrophy.
    Sridhar MS, Rapuano CJ, Cosar CB, Cohen EJ, Laibson PR.
    Ophthalmology; 2002 Apr 11; 109(4):674-9. PubMed ID: 11927423
    [Abstract] [Full Text] [Related]

  • 39. Results from the multicenter Boston Type 1 Keratoprosthesis Study.
    Zerbe BL, Belin MW, Ciolino JB, Boston Type 1 Keratoprosthesis Study Group.
    Ophthalmology; 2006 Oct 11; 113(10):1779.e1-7. PubMed ID: 16872678
    [Abstract] [Full Text] [Related]

  • 40. The Boston keratoprosthesis type I in mucous membrane pemphigoid.
    Palioura S, Kim B, Dohlman CH, Chodosh J.
    Cornea; 2013 Jul 11; 32(7):956-61. PubMed ID: 23538625
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.